Literature DB >> 8021232

Transformation of Mycoplasma gallisepticum with Tn916, Tn4001, and integrative plasmid vectors.

J Cao1, P A Kapke, F C Minion.   

Abstract

Mycoplasma gallisepticum causes respiratory disease in avian species, but little is known about its mechanism(s) of pathogenesis. These studies were undertaken in order to develop genetic systems for analysis of potential virulence factors. M. gallisepticum was transformed with plasmids containing one of the gram-positive transposons Tn916 or Tn4001, which inserted randomly into the mycoplasmal chromosome. Plasmids containing cloned chromosomal DNA were also constructed and tested for integration into regions of DNA homology derived either from chromosomal fragments or from the gentamicin resistance marker from Tn4001. These studies demonstrate that M. gallisepticum is amenable to transformation with both transposons and integrative vectors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021232      PMCID: PMC205662          DOI: 10.1128/jb.176.14.4459-4462.1994

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  17 in total

1.  Development of a cloning system in Mycoplasma pulmonis.

Authors:  G G Mahairas; C Jian; F C Minion
Journal:  Gene       Date:  1990-09-01       Impact factor: 3.688

Review 2.  New perspectives in tetracycline resistance.

Authors:  A A Salyers; B S Speer; N B Shoemaker
Journal:  Mol Microbiol       Date:  1990-01       Impact factor: 3.501

3.  Random insertion of the gentamicin resistance transposon Tn4001 in Mycoplasma pulmonis.

Authors:  G G Mahairas; F C Minion
Journal:  Plasmid       Date:  1989-01       Impact factor: 3.466

4.  Location of sites of transposon Tn916 insertion in the Mycoplasma mycoides genome.

Authors:  J C Whitley; L R Finch
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

5.  Transformation of Mycoplasma pulmonis and Mycoplasma hyorhinis: transposition of Tn916 and formation of cointegrate structures.

Authors:  K Dybvig; J Alderete
Journal:  Plasmid       Date:  1988-07       Impact factor: 3.466

6.  Transposition of gram-positive transposon Tn916 in Acholeplasma laidlawii and Mycoplasma pulmonis.

Authors:  K Dybvig; G H Cassell
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

7.  Transformation of Mycoplasma pulmonis: demonstration of homologous recombination, introduction of cloned genes, and preliminary description of an integrating shuttle system.

Authors:  G G Mahairas; F C Minion
Journal:  J Bacteriol       Date:  1989-04       Impact factor: 3.490

8.  First step toward a virus-derived vector for gene cloning and expression in spiroplasmas, organisms which read UGA as a tryptophan codon: synthesis of chloramphenicol acetyltransferase in Spiroplasma citri.

Authors:  C Stamburski; J Renaudin; J M Bove
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

9.  Transformation of Acholeplasma laidlawii with streptococcal plasmids pVA868 and pVA920.

Authors:  K Dybvig
Journal:  Plasmid       Date:  1989-03       Impact factor: 3.466

10.  Spiroplasmas and the transfer of genetic material by transformation and transfection.

Authors:  J M Bove; T Candresse; C Mouches; J Renaudin; C Saillard
Journal:  Isr J Med Sci       Date:  1984-09
View more
  17 in total

1.  Phenotypic switching in Mycoplasma gallisepticum hemadsorption is governed by a high-frequency, reversible point mutation.

Authors:  Florian Winner; Ivana Markovà; Peter Much; Albin Lugmair; Karin Siebert-Gulle; Gunther Vogl; Renate Rosengarten; Christine Citti
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

2.  GAA trinucleotide repeat region regulates M9/pMGA gene expression in Mycoplasma gallisepticum.

Authors:  L Liu; K Dybvig; V S Panangala; V L van Santen; C T French
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Identification of a virulence-associated determinant, dihydrolipoamide dehydrogenase (lpd), in Mycoplasma gallisepticum through in vivo screening of transposon mutants.

Authors:  P Hudson; T S Gorton; L Papazisi; K Cecchini; S Frasca; S J Geary
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

4.  A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes.

Authors:  W R Lyon; C M Gibson; M G Caparon
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

5.  Gene transfer in Mycoplasma arthritidis: transformation, conjugal transfer of Tn916, and evidence for a restriction system recognizing AGCT.

Authors:  L L Voelker; K Dybvig
Journal:  J Bacteriol       Date:  1996-10       Impact factor: 3.490

6.  Homologue of macrophage-activating lipoprotein in Mycoplasma gallisepticum is not essential for growth and pathogenicity in tracheal organ cultures.

Authors:  Philip F Markham; Anna Kanci; György Czifra; Bo Sundquist; Peter Hains; Glenn F Browning
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

7.  Versatile use of oriC plasmids for functional genomics of Mycoplasma capricolum subsp. capricolum.

Authors:  Carole Janis; Carole Lartigue; Joachim Frey; Henri Wróblewski; François Thiaucourt; Alain Blanchard; Pascal Sirand-Pugnet
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

8.  Gene disruption through homologous recombination in Spiroplasma citri: an scm1-disrupted motility mutant is pathogenic.

Authors:  S Duret; J L Danet; M Garnier; J Renaudin
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

Review 9.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

10.  New selectable marker for manipulating the simple genomes of Mycoplasma species.

Authors:  Mikkel A Algire; Carole Lartigue; David W Thomas; Nacyra Assad-Garcia; John I Glass; Chuck Merryman
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.